EYA2 and breast carcinoma: It is reported that knockdown Eya2 deletion in breast carcinoma cells inversed Six1 ability to facilitate TGF-β pathway, as well as to promote properties correlated with EMT and CSCs, proposing that Six1-dependentm Eya2 process to regulate a variety of pro-metastatic features [60].